Antimalarial activity against schizont stage of chloroquine-susceptible Plasmodium falciparum 3D7 infected in erythrocytes assessed as inhibition of [3H]hypoxanthine incorporation after 48 hrs by scintillation counting analysis
Antimalarial activity against schizont stage of chloroquine-susceptible Plasmodium falciparum 3D7 infected in erythrocytes assessed as inhibition of [3H]hypoxanthine incorporation after 96 hrs by scintillation counting analysis
Antimalarial activity against schizont stage of chloroquine-resistant Plasmodium falciparum W2 infected in erythrocytes assessed as inhibition of [3H]hypoxanthine incorporation after 48 hrs by scintillation counting analysis
Antimalarial activity against schizont stage of chloroquine-resistant Plasmodium falciparum W2 infected in erythrocytes assessed as inhibition of [3H]hypoxanthine incorporation after 96 hrs by scintillation counting analysis
Antimalarial activity against schizont stage of atovaquone-resistant Plasmodium falciparum Tm90C2b infected in erythrocytes assessed as inhibition of [3H]hypoxanthine incorporation after 48 hrs by scintillation counting analysis
Antimalarial activity against schizont stage of atovaquone-resistant Plasmodium falciparum Tm90C2b infected in erythrocytes assessed as inhibition of [3H]hypoxanthine incorporation after 96 hrs by scintillation counting analysis
Antitoxoplasma activity against Toxoplasma gondii RH tachyzoites isolated from human brain assessed as parasite growth inhibition after 24 hrs by hematoxylin-eosin staining based light microscopy
Antitoxoplasma activity against Toxoplasma gondii RH tachyzoites isolated from human brain assessed as parasite growth inhibition after 48 hrs by hematoxylin-eosin staining based light microscopy
Antitrypanosomal activity against Trypanosoma brucei gambiense FeoITMAP/1893 assessed as inhibition of parasite growth after 72 hrs by resazurin dye based microplate reader analysis
Antitrypanosomal activity against Trypanosoma brucei brucei CMP infected in Swiss mouse assessed as mean survival time at 100 umol/kg, ip administered as single dose
Antitrypanosomal activity against Trypanosoma brucei brucei CMP infected in Swiss mouse assessed as mean survival time at 50 umol/kg, ip administered as single dose
Antitrypanosomal activity against Trypanosoma brucei brucei CMP infected in Swiss mouse assessed as cure rate at 100 umol/kg, ip administered as single dose
Antitrypanosomal activity against Trypanosoma brucei brucei CMP infected in Swiss mouse assessed as cure rate at 50 umol/kg, ip administered as single dose